跳至主要内容
临床试验/NL-OMON29886
NL-OMON29886尚未招募不适用

Clinical Evaluation of the PCA3 Assay in Men Requiring a Repeat Biopsy - Clinical Evaluation of the PCA3 Assay in Men Requiring a Repeat Biopsy

Gen-Probe Incorporated, European Office0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • The subject*s last prostate biopsy must have been performed greater than 3 months prior to enrollment and must have been negative for cancer. The previous biopsy must have included at least 6 cores and the pathology report must be available.

排除标准

  • More than 2 previous prostate biopsies
  • Use of finasteride, dutasteride, leuprolide acetate, or other medications or hormones (within the past 3 months) that are known to affect serum PSA levels
  • Symptoms of urinary tract infection (including prostatitis) at the time of enrollment
  • History of prostate cancer
  • History of invasive treatments for BPH or lower urinary tract symptoms (LUTS), eg, transurethral resection of the prostate (TURP), heat, laser, or ultrasound treatments in the last 6 months

研究者

发起方
Gen-Probe Incorporated, European Office

相似试验